Refine by
In Vitro Study Suppliers Serving Qatar
45 companies found
based inParis, FRANCE
Laboratoires Fillmed : A French major playor with an objective of 360° approach to skin rejuvenation. Founded in 1978, FILLMED has been developing high performance products to prevent and correct signs of skin ageing: ART FILLER dermal fillers, NCTF ...
based inVancouver, BRITISH COLUMBIA (CANADA)
Since 1990, Aurora has been serving the global scientific research community through the development of innovative laboratory solutions. Headquartered in Vancouver, Canada, the company started manufacturing analytical instrumentation based on a ...
based inAlachua, FLORIDA (USA)
RTI Surgical (RTI) is a global, industry leading surgical implant supplier that provides design, new product development, processing and manufacturing services in support of patients and leading medical technology companies. With expertise in tissue ...
RTI Surgical offers the only meniscal allograft with both bone and meniscus sterilized through the BioCleanse® Tissue Sterilization Process. The BioCleanse processed meniscus graft provides a sterilized alternative to traditional aseptically ...
based inNess Ziona, ISRAEL
BiomX is developing both natural and engineered phage cocktails designed to target and destroy bacteria that affect the appearance of skin, as well as harmful bacteria in chronic diseases, such as cystic fibrosis, inflammatory bowel disease, atopic ...
We are developing BX004, a phage therapy for CF patients with chronic Pseudomonas aeruginosa (P. aeruginosa) respiratory infections, a main contributor to morbidity and mortality in this disease. Phase 1b/2a clinical study in CF patients is composed ...
based inMississauga, ONTARIO (CANADA)
Covalon Technologies Ltd. (Covalon) develops and commercializes proprietary technologies for major medical device manufacturers. Our partners include the top medical device companies, leaders in urology, wound care, vascular access, venture capital, ...
A highly versatile coating, CovaCoat is a photochemical process, that enables permanent covalent attachment of the coating to a wide variety of medical devices. Each formulation is specifically tailored to the device, and can be engineered to ...
based inMontreal, QUEBEC (CANADA)
SCIREQ strives to make a strong impact on global pulmonary health by empowering scientists to better understand and eradicate lung diseases. The global burden of respiratory diseases is primarily driven by asthma, chronic obstructive pulmonary ...
based inPhiladelphia, PENNSYLVANIA (USA)
Allevi creates tools and solutions to design, engineer and build with life. Our 3D bioprinters and bioinks are used around the world to find solutions to humanity’s most difficult problems – to cure disease, to test novel drugs, and to eliminate the ...
based inFlorham Park, NEW JERSEY (USA)
Celularity, headquartered in Florham Park, N.J., is a clinical stage biotechnology company leading the next evolution in cellular medicine by delivering off-the-shelf allogeneic placenta-derived cellular therapies at unparalleled scale, quality and ...
We are developing CYNK-101 as a combination treatment for multiple cancer indications. CYNK-101 is manufactured from a specific type of immune cell, NK cells, that we extract from postpartum placentas and then genetically engineer to increase cell ...
based inTrabzon, TURKEY
Dogsan, the first suture manufacturer of Turkey, Middle East and Balkan states, is founded in 1970 and have a long history in suture manufacturing. Competing with the global brands, Dogsan have gained its power from 45 year of expertise, almost 50 ...
PEGELAK sutures are synthetic absorbable sterile surgical sutures which are flexible strands composed of a copolymer prepared and synthesized from 90 percent glycolide and 10 percent L-lactide (derived from glycolic and lactic acids) and are ...
based inYuseong-gu, SOUTH KOREA
We strive to become a leading biotech company that contributes to human health and well-being by providing innovative therapeutic antibodies to patients with unmet medical needs. We have been committed to developing novel antibody therapeutics since ...
PMC-402 is a monoclonal antibody that targets the human TIE2 that regulated activation, proliferation, and repolarization of Tie2 expressing macrophages, resulting in T cell activation. It binds to TIE2 expressing macrophages that activate T cells ...
based inShanghai, CHINA
Bioventus LLC is a medical technology company that specializes in the development and distribution of orthobiologic solutions designed to support bone healing and regeneration. The company is known for its registered trademarks such as OSTEOAMP, ...
OSTEOAMP is backed by science to meet the surgeon's need for a proven allograft that can achieve solid fusion ...
based inMelbourne, AUSTRALIA
Starpharma Holdings Limited is a global biopharmaceutical company and a world leader in the development of new pharmaceutical and medical products based on proprietary polymers called dendrimers, with programs for COVID-19, DEP drug delivery and ...
based inGuildford, UNITED KINGDOM
Futura Medical is a pharmaceutical company developing a portfolio of innovative products based on our proprietary, transdermal DermaSys technology. Futura Medical is an innovative R&D company with a pipeline of products in late stage development. ...
Scientific advisory meeting held with MHRA confirming the need of a Phase 3 study to support the improved skin permeation including potential superior efficacy claims. Exploring the feasibility of a clinical study to satisfy the Phase 3 requirements ...
based inShanghai, CHINA
Focusing on the core raw materials of the life science industry, Yeasen Biotechnology (Shanghai) Co., Ltd. is a biotechnology company engaged in the research and development, production and sales of three major categories of biological reagents: ...
Ceturegel matrix, a kind of basement membrane matrix, is a soluble basement membrane preparation extracted from EHS mouse tumors rich in extracellular matrix proteins. It also contains growth factors such as TGF-beta, EGF, IGF, FGF and other related ...
based inLa Verpillière, FRANCE
As a world-leading drug delivery device solutions provider, our purpose of putting patients first enables us to design and manufacture devices that maximize treatment efficacy. We are a holistic partner and help our customers succeed in the sprint ...
Off-the-shelf devices available for key identified nasal drugs. Accelerate your sprint to market with our Device Equivalence Program. Based on FDA requirements, we have established a Device Equivalence Program in order to accelerate ...
based inDiepenbeek, BELGIUM
Founded in 2012, InnoSer is an innovative and dynamic contract research organization supporting preclinical development of drugs from its facilities in Belgium and the Netherlands. InnoSer supports its customers in the critical steps of their drug ...
We have specialized facilities for in vitro and in vivo offerings. Our established scientific experience and customized, collaborative approach make InnoSer the ideal ally for your company to achieve meaningful, high-quality and fast results. ...
based inRio Grande, NEW JERSEY (USA)
We deliver wound therapies for superior outcomes. AediCell provides safe, effective, and easy to use products at a lower overall cost. Aedicell® is a regenerative medicine company that has developed a unique proprietary process to transform human ...
The only product on the market that combines human tissue sourced from the amniotic/chorionic membrane, umbilical cord AND placental disc —Dermavest®. This combination delivers a myriad of cell attachment proteins (CAP) including collagen, ...
based inHudson, MASSACHUSETTS (USA)
Proveris Scientific specializes in providing advanced instrument and laboratory services for testing solutions in the development and manufacturing of oral inhalation and nasal drug products (OINDP). They are recognized globally for their expertise ...
based inLodi, WISCONSIN (USA)
Attwill develops and manufactures pharmaceuticals, medical devices, and biologics in the heart of Wisconsin. Attwill’s scalable production and funding solutions are well equipped to take new ideas from startup to scale. With lyophilization at ...
FILTERGuard™ is a disposable IV filter with CHG. The sterile, single-use disposable IV filter is infused with chlorhexidine gluconate (CHG) to help reduce the incidence of bloodstream infections, local infections and skin colonization in ...
based inCambridge, MASSACHUSETTS (USA)
Sumitomo Pharma Oncology, Inc. is a developer of novel cancer therapeutics based in the U.S. and a wholly owned subsidiary of Sumitomo Pharma Co., Ltd. This U.S. entity, together with the oncology research and development teams in Japan, Cancer ...
TP-0184 is an investigational inhibitor of activin receptor-like kinase 2 (ALK2) and ALK5 (also known as TGFβR1). This bimodal inhibitor is believed to downregulate multiple TGF-β superfamily signaling pathways and has shown antitumor ...
